Early
Mild degeneration, first presentation
Early OA or early tendinopathy. Symptoms present but structure still largely preserved.
- PT first
- PRP for tendon
- Injection for flare
The alternatives to joint replacement surgery.
Four options sit short of a joint replacement: physical therapy, cortisone or hyaluronic acid injections, PRP, and MSC (mesenchymal stem cell) therapy. None is right for every joint. Each addresses a different problem at a different stage, and sometimes the replacement is the answer.
Medically reviewed by the physician team at Hospital Angeles ยท October 2026
Which option fits which stage?
Three things decide it: severity, structure, and your goals. Without those, comparing options is noise.
Middle
Moderate, plateaued on conservative
Moderate OA with partial joint-space preservation. Surgery has been raised but isn't urgent.
- MSC therapy considered
- PT maintained
- Surgery on the table
Late
End-stage, bone-on-bone
Advanced OA, subchondral bone loss, mechanical instability. Function severely limited.
- Replacement often appropriate
- MSC case-by-case if you want to delay replacement
- Lower expected response
Five questions worth asking your surgeon
If you've been recommended a joint replacement, these five questions sort an "inevitable" recommendation from a conservatively-timed one. Bring this list to your next appointment.
What's my realistic functional outcome?
Not "you'll walk again." Specific return-to-activity and timeline against your own baseline.
What are the complication rates, yours?
Published rates are aggregate. Your individual surgeon's rates for this specific procedure are what matter.
Have I been evaluated for regenerative therapy?
If the answer is "no" or "that doesn't work," ask what criteria were used.
What happens if I wait 6 to 12 months?
Genuine progressive pathology looks different from "now is as good as any." The distinction is worth hearing.
If this doesn't achieve my outcome, what's next?
Revision surgery, conversion procedures, and lifetime hardware management are real considerations, especially if you're under sixty.
When is surgery the right answer?
The physician team declines a significant share of inquiries. Patients who have crossed structural thresholds where biology can no longer reach deserve an honest answer, not a sales pitch.
- Avascular necrosis with subchondral collapse.
- Massive retracted rotator cuff tears.
- Spinal instability with neurologic compromise.
These are surgical cases, and good surgery is excellent medicine. (A contained herniated disc, even with a fusion offered, is the spine case we evaluate individually.)
End-stage osteoarthritis with bone-on-bone contact often falls here too, but if you want to delay replacement, we'll still consider treating you, just with a frank conversation about the lower expected response.
MSC therapy isn't a universal alternative to surgery. It's one option with a specific candidate profile. When surgery is the right call, we'll tell you, and refer you to surgeons whose outcomes we trust.
If you're reading marketing that promises regenerative therapy "beats surgery" for every patient, close the tab. That claim is false, and anyone making it is selling you something.
Common questions
Is regenerative therapy always better than surgery?
No. It has a specific candidate profile. For patients with moderate degeneration, it's a legitimate option to evaluate first. For end-stage disease, surgery is often the right answer, but if you want to delay it, we'll still consider treating you with a frank conversation about the lower expected response.
Can I do MSC therapy and still have surgery later if needed?
In most cases, yes. MSC therapy doesn't disqualify you from future replacement and doesn't complicate surgical planning. If your case later progresses, the surgical option remains.
What about cortisone, is it harmful?
Occasional cortisone for flare management is reasonable. Repeated high-frequency cortisone may accelerate cartilage loss in some patients and is increasingly discouraged for chronic OA. Ask about dose and frequency before agreeing to a series.
How do I choose between PRP and MSC therapy?
PRP is often reasonable for tendinopathy and mild OA. MSCs have broader application for moderate OA and post-injury degeneration. The candidate profiles differ, and the evaluation decides.
Bring us your imaging.
The honest answer starts with a Celva patient coordinator collecting your imaging and goals, and Celva's physician team reading them. If surgery is right, they'll say so. If MSC therapy is reasonable, they'll explain why. Neither answer comes off a package menu.
Not medical advice. Individual results vary. Candidacy is physician-determined against imaging and history.